Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2

被引:65
作者
Lopes, Graciliana [1 ]
Andrade, Paula B. [1 ]
Valentao, Patricia [1 ]
机构
[1] Univ Porto, Dept Quim, Lab Farmacognosia, Requimte LAQV,Fac Farm, Rua Jorge Viterbo Ferreira 228, P-4050313 Porto, Portugal
关键词
phlorotannins; diabetes mellitus; hyperglycaemia; alpha-glucosidase; postprandial glucose; advanced glycation end-products; pancreatic beta-cells; glucotoxicity; ALLEVIATES POSTPRANDIAL HYPERGLYCEMIA; REDUCING OXIDATIVE STRESS; AMYLASE-INHIBITORY-ACTIVITIES; ALDOSE REDUCTASE INHIBITOR; POTENT ALPHA-GLUCOSIDASE; ECKLONIA-CAVA PROTECTS; GLYCATION END-PRODUCTS; PANCREATIC BETA-CELLS; BROWN ALGA; ISHIGE-OKAMURAE;
D O I
10.3390/molecules22010056
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetes mellitus is a group of metabolic disorders characterized by hyperglycaemia, and predicted by the World Health Organization as the expected 7th leading cause of death in 2030. Diabetes mellitus type 2 (DMT2) comprises the majority of diabetic individuals around the world (90%-95%). Pathophysiologically, this disorder results from a deregulation of glucose homeostasis, worsened by overweight and by a sedentary lifestyle, culminating in life-threatening cardiovascular events. The currently available anti-diabetic drugs are not devoid of undesirable side effects, sometimes responsible for poor therapeutic compliance. This represents a challenge for contemporary medicine, and stimulates research focused on the development of safer and more efficient anti-diabetic therapies. Amongst the most promising sources of new bioactive molecules, seaweeds represent valuable, but still underexploited, biofactories for drug discovery and product development. In this review, the role of phlorotannins, a class of polyphenols exclusively produced by brown seaweeds, in the management of DMT2 will be discussed, focusing on various pharmacologically relevant mechanisms and targets, including pancreatic, hepatic and intestinal enzymes, glucose transport and metabolism, glucose-induced toxicity and beta-cell cytoprotection, and considering numerous in vitro and in vivo surveys.
引用
收藏
页数:21
相关论文
共 96 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Classification and Diagnosis of Diabetes [J].
不详 .
DIABETES CARE, 2015, 38 :S8-S16
[4]  
[Anonymous], 2012, LAB0167100
[5]  
[Anonymous], 2008, BAYER PRECOSE PRESCR
[6]  
[Anonymous], 2016, ISBN, V978, P88
[7]   Bioactive Compounds from Macroalgae in the New Millennium: Implications for Neurodegenerative Diseases [J].
Barbosa, Mariana ;
Valentao, Patricia ;
Andrade, Paula B. .
MARINE DRUGS, 2014, 12 (09) :4934-4972
[8]  
Barde S R., 2015, Asian Pacific Journal of Tropical Disease, V5, pS209, DOI [DOI 10.1016/S2222-1808(15)60891-X, 10.1016/S2222-1808(15)60891-X]
[9]   Novel concepts in insulin regulation of hepatic gluconeogenesis [J].
Barthel, A ;
Schmoll, D .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (04) :E685-E692
[10]  
BARZILAI N, 1993, J BIOL CHEM, V268, P25019